Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Skin Image Reference Tool to Aid Healthcare Providers' Diagnosis

for
Dermatologic Disease
Location: Winston-Salem NC
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 10+

Code: NCT07033169

Recruiting

PTT-936 Alone or in Combination in Patients With Locally Advanced or Metastatic Solid Tumors

for
Locally Advanced or Metastatic Solid Tumors
Location: Margate FL, San Antonio TX, Beverly Hills CA
Sponsor: Pyrotech Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06244992

Phase 1, Phase 2, Recruiting

Breast Mapping and Detection of Suspicious Breast Lesions Using Feminai

for
Breast Cancer Awareness
Location: Frisco TX
Sponsor: Feminai

Sex: Female

Age: 25 - 70+

Code: NCT07220863

Recruiting

First-in-Human Trial of VBC101 in Participants With Advanced Solid Tumor Malignancies

for
Participants With Advanced Solid Tumor Malignancies
Location: Fairfax VA, Grand Rapids MI, Houston TX, San Antonio TX,
Sponsor: VelaVigo Bio Inc

Sex: All

Age: 18+

Code: NCT07136779

Phase 1, Phase 2, Recruiting

Social and Environmental Determinants of Breast Cancer Survivorship: the Black Breast Cancer Survivor's Intervention (BBCSI)

for
Breast Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 18+

Code: NCT06885203

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab

for
Advanced Solid Tumor
Location: Boston MA, Nashville TN, Scottsdale AZ
Sponsor: Strand Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT07751042

Phase 1, Phase 2, Recruiting

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Boston MA, New York NY, Fairfax VA, Huntersville NC,
Sponsor: Arvinas Inc.

Sex: All

Age: 18+

Code: NCT07749586

Phase 1, Phase 2, Recruiting

M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors

for
Advanced Solid Tumor
Location: New Haven CT, New York NY, Toronto, San Antonio TX
Sponsor: EMD Serono Research & Development Institute, Inc.

Sex: All

Age: 18+

Code: NCT07166601

Phase 1, Recruiting

Fostering Oral Chemotherapy Understanding and Safety (FOCUS) Study

for
Cancer
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT06952790

Recruiting

A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Cancer

for
Breast Cancer
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07218250

Recruiting

Elacestrant vs Elacestrant Plus a CDK4/6 Inhibitor in Patients With ERpositive/HER2-negative Advanced or Metastatic Breast Cancer

for
Estrogen-receptor-positive Breast Cancer,
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT06062498

Phase 2, Recruiting

A Study of the TheraBionic P1 Device in Breast Cancer

for
Breast Cancer Stage I, Breast Cancer Stage II,
Location: Port Huron MI, Detroit MI, Farmington Hills MI,
Sponsor: Barbara Ann Karmanos Cancer Institute

Sex: Female

Age: 22+

Code: NCT07218432

Recruiting

Study of Naxitamab and Sacituzumab Govitecan in Patients With Metastatic Triple-negative Breast Cancer (TNBC)

for
Metastatic Triple-Negative Breast Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07011654

Phase 1, Phase 2, Recruiting

Evaluation and Outcomes of SAVI Scout MD for Localized Breast Surgery

for
Breast Cancer
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: Female

Age: 18+

Code: NCT07686250

Phase 2, Recruiting

A Registry Study of Breast Microseed Treatment

for
Breast Neoplasms
Location: Fredericksburg VA, Pittsburgh PA, Seattle WA
Sponsor: Concure Oncology-Breast Microseed Inc.

Sex: Female

Age: 50+

Code: NCT02701244

Recruiting

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

for
HER2-positive Breast Cancer, Breast Cancer
Location: Scarborough ME, Boston MA, New York NY, Norfolk VA,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07102381

Phase 2, Recruiting

Project SOAR (Speaking Our African American Realities) Awakenings for Black American Women Diagnosed With Breast Cancer

for
Breast Cancer
Location: Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: Female

Age: 18+

Code: NCT07208084

Recruiting

The TIOB - Collection of Patients' Biospecimens for Analysis of Immunological and Molecular Biomarkers.

for
Cancer
Location: College Station TX, Plano TX, Dallas TX, Waxahachie TX,
Sponsor: Baylor Research Institute

Sex: All

Age: 18+

Code: NCT05371756

Recruiting

A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies

for
Solid Tumor Malignancies
Location: Fairfax VA, Miami FL, Cincinnati OH, Grand Rapids MI,
Sponsor: Kumquat Biosciences Inc.

Sex: All

Age: 18+

Code: NCT07207707

Phase 1, Recruiting

Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk

for
Breast Carcinoma
Location: Jacksonville FL, Rochester MN
Sponsor: Mayo Clinic

Sex: Female

Age: 18 - 70+

Code: NCT07207564

Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial